Proposal, discussion, and, if applicable, approval for (a) the Company to carry out, directly or indirectly, one or more acquisitions of exploration and/or exploitation rights, interests in concessions, licenses, and agreements for the development of unconventional hydrocarbon reserves and resources and/or any other assets related to the development of unconventional hydrocarbon reserves and resources located in basins where the Company operates, including the acquisition and/or participation in entities holding such assets (any of these, a “Potential Acquisition”), which total amount represents more than 20% of the value of the Company’s consolidated assets (based on figures as of the end of the last quarter reported at the time of executing the first of such Possible Acquisitions or of executing the Potential Acquisition, if only one is executed), with the understanding that if the Potential Acquisition (or Potential Acquisitions, as a whole) represents an equal or lower percentage, it (or they) will not be subject to the present approval; and further understanding that the total amount of the Potential Acquisition or Potential Acquisitions may not exceed, in the aggregate and within a period of 12 months from the date of the Ordinary General Meeting, 50% of the value of the consolidated assets of the Company (based on figures as of the end of the last quarter reported at the time of executing the first of such Potential Acquisition or of executing the Potential Acquisition, if only one is executed); and (b) the delegation to the Company’s Board of Directors of the authority to determine all final terms, conditions and characteristics to which the Potential Acquisition(s) shall be subject; provided that such approval will revoke and replace, for all legal purposes, the authorization granted, with respect to the same matters, by the ordinary general shareholders’ meeting dated March 3, 2025 (the “2025 Shareholders’ Meeting”), without such circumstance affecting the validity of any acts that have been performed, are pending execution, or whose execution continues, under the authorizations granted by the 2025 Shareholders’ Meeting. Resolutions in this regard.

Proposal, discussion, and, if applicable, approval for the Company, and/or any of its direct and indirect subsidiaries, regardless of their place of incorporation to incur any type of financing debt to pay in full or in part for the Potential Acquisition or Potential Acquisitions; provided that such approval will revoke and replace, for all legal purposes, the authorization granted, with respect to the same matters, by the 2025 Shareholders’ Meeting, without such circumstance affecting the validity of any acts that have been performed, are pending execution, or whose execution continues, under the authorizations granted by the 2025 Shareholders’ Meeting; resolutions in this regard.

Proposal, discussion and, if applicable, approval to (a) delegate to the Company’s Board of Directors the authority to resolve one or more increases to the variable portion of the Company’s capital stock to pay, in whole or in part, the Potential Acquisition(s) or any other acquisition substantially similar to a Potential Acquisition that, without being part of the approval contemplated in the preceding item of the agenda, is carried out by the Company within the 12-month period from the date of the Ordinary General Shareholders’ Meeting (each, an “Other Acquisition”), as well as the authority to determine the terms of the issuance, subscription and payment of the Series A shares representing such increases (which may be represented by ADSs); it being understood that preemptive rights will be excluded in connection with the issuances of such Series A shares and that the issuance of such Series A shares, in the aggregate, shall not exceed the number of shares representing 15% of the Series A shares outstanding representing the Company’s capital stock immediately prior to the occurrence of a first capital increase (or the capital increase, if there is only one) to fund the first of the Potential Acquisitions or Other Acquisitions (or the Potential Acquisition or Other Acquisition, if only one); and (b) use any Series A shares held in the Company’s treasury to represent the capital increases that, as the case may be, are resolved by the Board of Directors pursuant to the foregoing sub-item; it being understood that this approval will revoke and replace, for all legal purposes, the authorization granted, with respect to the same matters, by the 2025 Shareholders’ Meeting, without such circumstance affecting the validity of any acts that have been performed, are pending execution, or whose execution continues, under the authorizations granted by the 2025 Shareholders’ Meeting. Resolutions in this regard.

Appointment of delegates to comply with and, as appropriate, formalize the resolutions adopted at the Ordinary General Meeting; associated resolutions.